Effect of Carbon Sources, Nitrogen Sources and Prebiotics on Growth of Saccharomyces Boulardii

1. Akil, I., Yilmaz, O., Kurutepe, S., Deqerli, K., Kavukcu, S. (2006). Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora. Pediatric nephrology, 21(6), 807-810. http://dx.doi.org/10.1007/s00467-006-0088-410.1007/s00467-006-0088-416703374Open DOISearch in Google Scholar

2. Anvari, M., Khayati, G., Rostami, S. (2013). Optimisation of medium composition for probiotic biomass production using response surface methodology. Journal of Dairy Research, 81(01), 59–64. http://dx.doi.org/10.1017/s002202991300073310.1017/s0022029913000733Open DOISearch in Google Scholar

3. Buts, J. P., Dekeyser, N., Stilmant, C., Delem, E., Smets, F., Sokal, E. (2006). Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coil endotoxin by dephosphorylation. Pediatric Research, 60(1), 24-29. http://dx.doi.org/10.1203/01.pdr.0000220322.31940.2910.1203/01.pdr.0000220322.31940.2916690953Open DOISearch in Google Scholar

4. Cheng, Fangfang., Chen, He., Lei, Ni., Zhang, Meng., Wan, Hongchang., Shu, Guowei. (2019). Effect of prebiotics, inorganic salts and amino acids for cell envelope proteinase production from Lactobacillus plantarum LP69. Acta scientiarum polonorum. Technologia alimentaria, 18(3). http://dx.doi.org/10.17306/J.AFS.065610.17306/J.AFS.065631569909Search in Google Scholar

5. Corona-Hernandez, R. I., Álvarez-Parrilla, E., Lizardi-Mendoza, J., Islas-Rubio, A. R., de la Rosa, L. A., Wall-Medrano, A. (2013). Structural Stability and Viability of Microencapsulated Probiotic Bacteria: A Review. Comprehensive Reviews in Food Science and Food Safety, 12(6), 614–628. http://dx.doi.org/10.1111/1541-4337.1203010.1111/1541-4337.1203033412721Open DOISearch in Google Scholar

6. Czerucka, D., Piche, T., Rampal, P. (2010). Review article: yeast as probiotics -- Saccharomyces boulardii. Alimentary Pharmacology & Therapeutics, 26(6), 767-778. http://dx.doi.org/10.1111/j.1365-2036.2007.03442.x10.1111/j.1365-2036.2007.03442.x17767461Open DOISearch in Google Scholar

7. Edwards-Ingram, L., Gitsham, P., Burton, N., Warhurst, G., Clarke, I., Hoyle, D., Oliver, S. G., Stateva, L. (2007). Genotypic and physiological characterization of Saccharomyces boulardii, the proboscis strain of Saccharomyces cerevisiae. Applied and Environmental Microbiology, 73(8), 2458-2467. http://dx.doi.org/10.1128/AEM.02201-0610.1128/AEM.02201-06185559417293506Open DOISearch in Google Scholar

8. Elmer, G. W., Mcfarland, L. V., Surawicz, C. M., Danko, L., Greenberg, R. N. (2000). Behaviour of saccharomyces boulardii in recurrent clostridium difficile disease patients. Alimentary Pharmacology & Therapeutics, 13(12), 1663-1668. http://dx.doi.org/10.1046/j.1365-2036.1999.00666.x10.1046/j.1365-2036.1999.00666.x10594402Search in Google Scholar

9. Fietto, J. L., Araújo, R. S., Valadão, F. N., Fietto, L. G., Brandão, R. L., Neves, M. J., Gomes, F. C., Nicoli, J. R., Castro, I. M. (2004). Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Canadian Journal of Microbiology, 50(8), 615- 621. http://dx.doi.org/10.1139/w04-05010.1139/w04-05015467787Search in Google Scholar

10. George Kerry, R., Patra, J. K., Gouda, S., Park, Y., Shin, H.-S., Das, G. (2018). Benefaction of probiotics for human health: A review. Journal of Food and Drug Analysis, 26(3), 927–939. http://dx.doi.org/10.1016/j.jfda.2018.01.00210.1016/j.jfda.2018.01.00229976412Search in Google Scholar

11. Ghasem, B., Hosnie, G., Bahare, Z., Najmeh, Z., Farzin, R., Ardakani, E.M., Azizi, M., Khalaj, V. (2018). Oral administration of recombinant Saccharomyces boulardii expressing ovalbumin-cpe fusion protein induces antibody response in mice. Frontiers in Microbiology, 9, 723-. http://dx.doi.org/10.3389/fmicb.2018.0072310.3389/fmicb.2018.00723Open DOISearch in Google Scholar

12. Kailasapathy, K. (2015). Encapsulation and controlled release techniques for administration and delivery of bioactive components in the health food sector. Nutraceutical and Functional Food Processing Technology, John Wiley & Sons, Ltd.10.1002/9781118504956.ch11Search in Google Scholar

13. Malgoire, J. Y., Bertout, S., Renaud, F., Bastide, J. M., Mallié, M. (2005). Typing of Saccharomyces cerevisiae clinical strains by using microsatellite sequence polymorphism, Journal of Clinical Microbiology, 43(3), 1133-1137. http://dx.doi.org/10.1128/JCM.43.3.1133-1137.200510.1128/JCM.43.3.1133-1137.2005Open DOISearch in Google Scholar

14. Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., Shafaghi, A. (2003). Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World Journal of Gastroenterology, 9(8), 1832-1833. http://dx.doi.org/10.3748/wjg.v9.i8.183210.3748/wjg.v9.i8.1832Open DOISearch in Google Scholar

15. McFarland, L. V. (2006). Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. American Journal of Gastroenterology, 101(4), 812-822. http://dx.doi.org/10.1111/j.1572-0241.2006.00465.x10.1111/j.1572-0241.2006.00465.xOpen DOISearch in Google Scholar

16. McFarland, L. V. (2010). Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World Journal of Gastroenterol, 16(18), 2202-2222. http://dx.doi.org/10.3748/wjg.v16.i18.220210.3748/wjg.v16.i18.2202Open DOISearch in Google Scholar

17. McGroarty, J. (1993). Probiotics use of lactobacilli in the human female urogenital tract. FEMS Immunology and Medical Microbiology, 6(4), 251-264. http://dx.doi.org/10.1111/j.1574-695X.1993.tb00337.x10.1111/j.1574-695X.1993.tb00337.xOpen DOISearch in Google Scholar

18. Perdigon, G., Alvarez, S., Rachid, M., Agüero, G., Gobbato, N. (1995). Immune system stimulation by probiotics. Journal of Dairy Science, 78 (7), 1597-1606. http://dx.doi.org/10.3168/jds.S0022-0302(95)76784-410.3168/jds.S0022-0302(95)76784-4Open DOISearch in Google Scholar

19. Prabhu, A. A., Mandal, B., Dasu, V. V. (2017). Medium optimization for high yield production of extracellular human interferon-γ from Pichia pastoris: A statistical optimization and neural network-based approach. Korean Journal of Chemical Engineering, 34(4), 1109–1121. http://dx.doi.org/10.1007/s11814-016-0358-110.1007/s11814-016-0358-1Open DOISearch in Google Scholar

20. Szajewska, H., Mrukowicz, J. (2005). Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology and Therapeutics, 22(5), 365-372. http://dx.doi.org/10.1111/j.1365-2036.2005.02624.x10.1111/j.1365-2036.2005.02624.x16128673Open DOISearch in Google Scholar

21. Szajewska, H., Skorka, A., Dylag, M. (2007). Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Alimentary Pharmacology and Therapeutics, 25(3), 257-264. http://dx.doi.org/10.1111/j.1365-2036.2006.03202.x10.1111/j.1365-2036.2006.03202.x17269987Open DOISearch in Google Scholar

22. Vanhee, L. M. E., Goemé F., Nelis, H. J., Coenye, T. (2010). Quality control of fifteen probiotic products containing Saccharomyces boulardii. Journal of Applied Microbiology, 109(5).10.1111/j.1365-2672.2010.04805.x20636342Search in Google Scholar